Hello, Guest
Login
Sign Up
 
 

Stocks Review: Cirrus Logic, Urban Outfitters, Aeropostale, Questcor Pharmaceuticals Inc

 
 
Repost This

Dallas, TX -- (SBWIRE) -- 03/07/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Cirrus Logic, Inc. (NASDAQ:CRUS) slipped 2.39% and closed at $22.47 on a traded volume of 4.27 million shares. Cirrus Logic has been reiterated by TheStreet Ratings as a buy with a ratings score of B-. Cirrus Logic, Inc. is a United States-based company, which supplies high-precision analog and digital signal processing components for audio and energy markets.

Is CRUS a Strong Buy After The Recent Gain? Let’s Find out Here

Urban Outfitters, Inc. (NASDAQ:URBN) moved down 2.33% and closed at $40.74 on a traded volume of 1.40 million shares. In the last one year, the stock is up over 45%. The 52-week range for the stock is $25.43 and $3.44.15.

Is URBN a Strong Buying Opportunity After The Recent Slump? Find out Here

Aeropostale, Inc. (NYSE:ARO) was down 2.28% and closed at $13.28 on a traded volume of 3.25 million shares. The Company will be holding its quarterly earnings conference call for all interested parties on March 14, 2013. Aeropostale, Inc. is a primarily mall-based, specialty retailer of casual apparel and accessories, principally targeting 14 to 17 year-old young women and men through its Aeropostale stores and 4 to 12 year-old kids through its P.S. from Aeropostale stores.

Should Investors Consider ARO After The Recent price Action? Get Free Trend Analysis Here

Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) decreased 2.27% and closed at $30.10 on a traded volume of 3.42 million shares. Questcor Pharmaceuticals has been upgraded by TheStreet Ratings from hold to buy. Questcor Pharmaceuticals, Inc. is a biopharmaceutical company. The Company’s primary product is H.P. Acthar Gel, an injectable drug that is approved by the United States Food and Drug Administration, for the treatment of 19 indications.

Should Investors Consider QCOR After The Recent price Action? Get Free Trend Analysis Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.